Novel serum biomarkers modified by the body mass index z-score for the detection of liver fibrosis and steatosis in children with chronic hepatitis C.
Maria Pokorska-ŚpiewakBarbara Kowalik-MikołajewskaMałgorzata AniszewskaMagdalena PlutaMagdalena MarczyńskaPublished in: BMC infectious diseases (2017)
Including the BMI z-score in serum biomarker formulas enhances their diagnostic ability to detect significant fibrosis and steatosis. B-AST may thus act as an effective alternative to liver biopsy.